News for Syngene International Limited (SYNGENE.NS)

Apr 24, 2025 / 05:30AM GMTOperator Ladies and gentlemen, good day and welcome to Q4 and full year ended March 2025 financial results conference call of Syngene

Indian equity markets suffered a brutal decline on Monday extending their losses for a third consecutive session, amid a global rout triggered by escalating trade tensions. The Nifty Midcap 100 plummeted 7.26% to 46,966.60—its lowest level in a month—as panic gripped investors across sectors following a steep sell-off in global equities.

Stocks including Tata Steel, Power Grid, Tata Consumer Products, Coal India, NMDC, JSW Energy, RITES, Siemens, Hindustan Copper will be in the spotlight on Wednesday, April 02.

PR NewswireBANGALORE, India, March 10, 2025 Expected to enhance global innovator flexibility with biologics drug substance facility in BaltimoreBANGALORE,

**media[545950]**

Syngene International Limited reports strong Q3 results with profit-after-tax of Rs 131 crore and revenue growth of 11%.

Buzzing Stocks Today, Stocks that will see action today: January 23, 2025 - Hindustan Unilever, HUDCO, Waaree Energies, Piramal Pharma, Paras Defence, Bharti Airtel, Laurus Labs, Samman Capital, Shiva Cement, Effwa Infra

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True North.

Biocon Ltd. sells 80 lakh Syngene shares in a Rs 686 crore block deal, retaining a 52.46% stake. The sale supports strategic alignment amid challenges in Q2 FY25.

Syngene CFO Sibaji Biswas resigns, Deepak Jain to take over; Jayashree Aiyar appointed CSO, driving scientific strategy and innovation.

The global preclinical CRO market size was valued at USD 8.62 billion in 2024. It is projected to reach USD 21.48 billion by 2033, growing at a CAGR of...

OneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopharma, was demerged from Strides Pharma and aims to list on BSE and NSE within a year. OneSource plans to reduce debt and expand its manufacturing capabilities.

Derivatives market update for Sept 17: The premium in Nifty Sept futures jumped to 58 pts, and Bank Nifty to 100 pts; whereas, the PCR declined to near 1 levels indicating positive to sideways trend.

Derivatives market update for Sept 11: Bank Nifty weekly options PCR stands at 0.9:1; key trigger point at 51,550. Premium in Bank Nifty futures down to 99 pts from 255 pts in just 3 trading sessions: F&O Insights

Derivatives market update for Sept 06: The Nifty PCR dipped from 0.74, while Bank Nifty to 0.78; reflecting a cautionary trend said Dhupesh Dhameja of SAMCO Securities. Max Financial see short buildup: F&O insights

Derivative market update for Wednesday, August 28: The Nifty September futures premium dipped from Rs 155 to Rs 116 yesterday; while, Bank Nifty futures premium declined to Rs 257 from Rs 328.

The Global Drug Discovery Outsourcing Services Market Size was Valued at USD 3.8 Billion in 2023 and the Worldwide Drug Discovery Outsourcing Services...

In 2024 so far, the Nifty MidCap and SmallCap indices have slid to the 100-DMA in times of a market correction, show charts; check key levels here

Nifty on Friday ended 98 points higher to form an Inside Bar candlestick pattern on the daily chart. If the headline index manages to hold Thursday's low of 21,932, a pullback looks possible to chartists.